The present invention relates to pharmaceutical formulation containing terahydrolipstatin as and active ingredient. Composition of present pharmaceutical formulation includes powder mix of tetrahdrolipstatin, polyvinyl pyrrolidone-coated silica, and pharmaceutically acceptable ingredients like a suitable filler and lubricant. The composition of present invention provides an easy way to oral formulations, for example tablets or hard gelatin capsules.
